Q1 2013 Drug Sales Data Released: Rough U.S Flu Season Boosts Numbers for Tamiflu

The latest U.S. drug sales data has been released by Drugs.com. The top five drugs have minor shifts in rank but exhibit positive growth for Q1 2013. Abilify, Otsuka’s second generation antipsychotic, and Nexium, AstraZeneca’s leading acid blocker, rank as the top two drugs by sales for the fourth quarter in a row. Both agents hover in the $1.5 billion range for quarterly sales. In addition, the Tamiflu statistics show that the most recent U.S. flu season hit long and hard.

View the data here…